Evaluation of the Access Bio CareStart rapid SARS-CoV-2 antigen test in asymptomatic individuals tested at a community mass-testing program in Western Massachusetts

Evaluation of the Access Bio CareStart rapid SARS-CoV-2 antigen test in asymptomatic individuals tested at a community mass-testing program in Western Massachusetts

Abstract Point-of-care antigen-detecting rapid diagnostic tests (RDTs) to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) represent a scalable tool for surveillance of active SARS-CoV-2 infections in the population. Data on the performance of these tests in real-world community s...

Full description

Bibliographic Details
Main Authors: Sara Suliman, Wilfredo R. Matias, Isabel R. Fulcher, Francisco J. Molano, Shannon Collins, Elizabeth Uceta, Jack Zhu, Ryan M. Paxton, Sean F. Gonsalves, Maegan V. Harden, Marissa Fisher, Jim Meldrim, Stacey Gabriel, Molly F. Franke, Deborah T. Hung, Sandra C. Smole, Lawrence C. Madoff, Louise C. Ivers
Format: Article
Language:English
Published: Nature Portfolio 2022-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-25266-3

Internet

https://doi.org/10.1038/s41598-022-25266-3

Similar Items